MONTELEONE, FABRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.458
EU - Europa 274
AS - Asia 204
OC - Oceania 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.941
Nazione #
US - Stati Uniti d'America 3.457
KR - Corea 75
SG - Singapore 75
IT - Italia 59
IE - Irlanda 57
CN - Cina 47
DE - Germania 47
UA - Ucraina 35
RU - Federazione Russa 26
GB - Regno Unito 12
FR - Francia 11
PL - Polonia 11
FI - Finlandia 6
SE - Svezia 6
AU - Australia 2
BR - Brasile 2
GR - Grecia 2
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
IN - India 1
JP - Giappone 1
LK - Sri Lanka 1
MY - Malesia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 3.941
Città #
Wilmington 1.063
Houston 944
Woodbridge 644
Chandler 121
Fairfield 120
Ann Arbor 65
Singapore 65
New York 58
Ashburn 55
Seattle 49
Cambridge 46
Dublin 46
Dearborn 40
Medford 26
Jacksonville 22
Rome 16
Lawrence 13
Roebling 12
Kraków 11
Santa Clara 11
Beijing 10
Moscow 7
Norwalk 7
Zhengzhou 7
Philadelphia 5
San Diego 5
San Jose 5
Redwood City 4
Shanghai 4
Detroit 3
Frankfurt am Main 3
Hefei 3
Kunming 3
Nanjing 3
Palo Alto 3
Seoul 3
Turin 3
Verona 3
Arosio 2
Camino al Tagliamento 2
Chongqing 2
Del Norte 2
Guangzhou 2
Helsinki 2
Lissone 2
Menlo Park 2
Milan 2
Munich 2
Nanchang 2
Parma 2
Pavia 2
Piove di Sacco 2
São Paulo 2
Ardea 1
Bangkok 1
Brno 1
Buffalo 1
Caserta 1
Central 1
Chengdu 1
Chiswick 1
Colombo 1
Fuzhou 1
Haikou 1
Hangzhou 1
Huzhou 1
Jinan 1
Jinhua 1
Kilburn 1
Kuala Lumpur 1
Lappeenranta 1
London 1
Mcallen 1
Mountain View 1
Novokuznetsk 1
Nürnberg 1
Paris 1
Pescara 1
Pomezia 1
Pullach im Isartal 1
Pune 1
Redmond 1
Saint Paul 1
Saint Petersburg 1
Stanmore 1
Strasbourg 1
Sydney 1
Toronto 1
Wakefield 1
Xian 1
Totale 3.575
Nome #
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis 423
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 389
Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain 369
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids 353
Reversible hyporegenerative anemia during natalizumab treatment 344
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 301
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 296
Safety, tolerability and effectiveness of dimethyl fumarate in multiple sclerosis: an independent, multicenter, real-world study 286
TRPV1 channels regulate cortical excitability in humans 263
Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis 262
Enhancing brain plasticity to contrast clinical progression in MS: a pilot study assessing the safety and efficacy of D-Aspartate 257
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 155
The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray) 147
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 46
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 35
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 27
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray) 27
CSF tau levels influence cortical plasticity in Alzheimer's disease patients 15
null 3
Totale 3.998
Categoria #
all - tutte 9.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.476


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020838 0 0 0 0 91 134 131 108 120 93 76 85
2020/2021723 80 92 81 92 72 87 76 85 14 20 14 10
2021/2022126 10 12 0 4 1 15 8 8 3 19 16 30
2022/2023322 24 22 42 65 19 55 27 16 32 2 11 7
2023/2024103 20 4 5 7 7 33 2 8 2 0 0 15
2024/2025129 15 64 25 19 6 0 0 0 0 0 0 0
Totale 3.998